Interventional: Page 98

Contrast agent osmolality makes no difference in PCI of renal disease patients
By Edward Susman
The type of contrast medium used in percutaneous coronary interventions (PCIs) makes no statistically significant difference in outcomes among chronic renal disease patients in terms of nephrotoxicity, according to a study by researchers from Germany. They presented their findings at the recent 2008 American College of Cardiology (ACC) meeting in Chicago.
April 16, 2008
Boston Scientific to buy CryoCor
By AuntMinnie.com staff writers
Interventional device developer Boston Scientific has inked a deal to buy cryoablation technology provider CryoCor of San Diego.
April 15, 2008
Boston Scientific inks deal with Surgi-Vision
By AuntMinnie.com staff writers
Interventional device developer Boston Scientific of Natick, MA, has inked an agreement with Surgi-Vision of Gaithersburg, MD, for the licensing and development of MRI-safe technology, the company reported.
April 14, 2008
Stereotaxis adds to executive lineup
By AuntMinnie.com staff writers
Image-guided interventional surgery firm Stereotaxis has named Kevin Shifrin as senior vice president of global marketing and business development, and Magnus Holm as general manager for Europe.
April 6, 2008
Cook wins injunction against Endologix
By AuntMinnie.com staff writers
Interventional technology firm Cook has received a preliminary injunction against Endologix of Irvine, CA, and four former sales representatives from violating noncompete agreements with Cook.
March 31, 2008
Study: If biopsy shows lobular neoplasia, proceed to surgery
By Kate Madden Yee
For many women with suspicious mammogram findings, minimally invasive biopsy has become the accepted clinical approach. But this protocol leaves some women vulnerable to underestimation of the extent of disease. U.S. researchers studied the rate and variables linked with cancer underestimation when lobular neoplasia is diagnosed with tissue-sampling biopsy, and concluded that all patients with lobular neoplasia at core or vacuum biopsy should undergo surgical excisional biopsy.
March 26, 2008
PLC to enroll patients in CIN study
By AuntMinnie.com staff writers
PLC Systems of Franklin, MA, has received conditional approval from the U.S. Food and Drug Administration (FDA) to begin enrollment in a trial to study its RenalGuard product for preventing contrast-induced nephropathy (CIN).
March 20, 2008
Cook begins Reform clinical trial
By AuntMinnie.com staff writers
Interventional technology firm Cook Medical has launched the Reform clinical trial, designed to evaluate its Formula balloon expandable stent for treating renal artery stenosis.
March 19, 2008
SIR study: Women not told of UFE option
By AuntMinnie.com staff writers
A study presented at this week's Society of Interventional Radiology (SIR) meeting in Washington, DC, found that women with uterine fibroids aren't being told that uterine fibroid embolization (UFE) is a treatment option for their condition.
March 18, 2008
Sink or swim: Why a hand sink is crucial in the MR suite
By Tobias Gilk
As MR is used for an increasing number of interventional applications, infection control provisions will continue to grow in importance, including hand sinks in the MR suite. MRI architectural consultant Tobias Gilk explains why MR suite providers and facilities need to plan for hand sinks for all future MRI installations, and addresses some of the technical challenges of installing hand sinks in the MRI suite.
March 13, 2008
Court ruling protects medical device makers
By AuntMinnie.com staff writers
Medical device manufacturers in the U.S. can't be held liable for damages from patients injured by their devices if the products followed federal regulatory standards, according to a U.S. Supreme Court ruling this week.
February 21, 2008
Interventionalists: Proceed with caution for mechanical blood clot removal
By Edward Susman
The best predictor of a good recovery after an ischemic stroke is how successfully the patient can be revascularized, according to the results of a multicenter trial that looked at the correlation between restoration of blood flow and outcomes. Neurointerventionalist Dr. Christopher Zylak recently offered his take on the trial, and discussed how to get the best treatment outcomes for the patient.
February 18, 2008
Previous Page
Page 98 of 184
Next Page